Amoebiasis is an important public health problem in developing countries. Entamoeba histolytica, the causative agent of amoebiasis, may develop resistance to nitroimidazoles, a group of drugs considered to be the most effective against this parasitic disease. Therefore, research on new drugs for the treatment of this common infection still constitutes an important therapeutic demand. In the pre...

Picroliv, an iridoid glycoside mixture, isolated from root and rhizome of Picrorhiza kurrooa known to possess significant hepatoprotective activity. Present study demonstrated the hepatoprotective potential of picroliv against thioacetamide and Entamoeba histolytica induced hepatic damage in rats, mastomys, and gerbils. Significant increase in the serum levels of hapatospecific markers was foun...

Entamoeba histolytica is a parasitic protozoan that caused amoebiasis or amoebic dysentery, it an intestinal disease which infects colon and liver Amoebic dysentery spread all over the world. E. causing death of human cells leading to develop invasion, ulceration intestine. However, amebic abscess (ALA) considers as major common extraintestinal by histolytica. The current study was designed est...

Cardiac tamponade secondary to perforation of a hepatic amoebic abscess developed six years after the patient had visited an area where Entamoeba histolytica is endemic. He was treated with metronidazole and imipenem, emergency percutaneous catheter drainage, and open surgical drainage.

BACKGROUND & OBJECTIVES Entamoeba histolytica, the causative agent of amoebiasis and amoebic liver abscess, lyses host cells by direct contact using surface lectins and releases cysteine proteinase (CP). Virulence of E. histolytica is directly related to activity of its CP. The relationship of CP activity and cytotoxicity has not been established. The present study was carried out to explore th...